Pay in 4 interest-free payments of $24.75 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
InChiKey: PLIVFNIUGLLCEK-UHFFFAOYSA-N
23)/b22-21+
and STAT-3
is a novel potent and selective inhibitor of ubiquitin-specific protease 7 (USP7) with an IC50 ~4
is a potent ErbB inhibitor for the treatment of cancer
GPR39-C3 - GPR39 Agonist. CAS# 1621175-65-2 size:2 mg solid InChiKey: PLIVFNIUGLLCEK-UHFFFAOYSA-NGPR39 C3, CAS No. 1621175 65 2, is the first potent, selective and orally bioavailable GPR39 agonist with an EC50 ~0. 8 nM for human GPR39 and ~0. 4 nM for rodent GPR39. It has no inhibitory effects (at 10 M) on a panel of kinases and exhibits no relevant binding affinity for the related ghrelin and neurotensin 1 receptors and other enzymes, transporters, and GPCRs. GPR39 C3 has excellent functional activity in physiologically relevant rodent cells